HIT Clinical Trials

84 recruitingLast updated: July 25, 2026

There are 84 actively recruiting hit clinical trials across 31 countries. Studies span Not Applicable, Phase 2, Phase 4, Early Phase 1, Phase 1, Phase 3. Top locations include New York, New York, United States, Pittsburgh, Pennsylvania, United States, Philadelphia, Pennsylvania, United States. Updated daily from ClinicalTrials.gov.


HIT Trials at a Glance

84 actively recruiting trials for hit are listed on ClinicalTrialsFinder across 6 cities in 31 countries. The largest study group is Not Applicable with 30 trials, with the heaviest enrollment activity in New York, Pittsburgh, and Philadelphia. Lead sponsors running hit studies include M.D. Anderson Cancer Center, Maia Kayal, and Monash University.

Treatments under study

About HIT Clinical Trials

Looking for clinical trials for HIT? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HIT trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HIT clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 84 trials

Recruiting
Not Applicable

Low Dose Radiotherapy for Osteoarthritis

Osteoarthitis
Abramson Cancer Center at Penn Medicine113 enrolled2 locationsNCT07715188
Recruiting
Phase 1Phase 2

An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease

Vanishing White Matter Disease
Calico Life Sciences LLC50 enrolled5 locationsNCT05757141
Recruiting
Not Applicable

Comparison of MI Paste Plus and Resin Infiltration in White Spot Lesions Following Orthodontic Treatment

White spot lesionsOrthodontic Appliance ComplicationCaries Arrested+1 more
University of Alberta62 enrolled1 locationNCT05733676
Recruiting
Phase 3

Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult Patients

BronchitisAcute Bronchitis
Materia Medica Holding308 enrolled33 locationsNCT07650227
Recruiting
Not Applicable

The Effectiveness of the Self-Assembling Peptide P11-4 in the Remineralization of Enamel Carious White Spot Lesions

White Spot Lesions on Smooth Surface of Tooth
Medical University of Warsaw75 enrolled1 locationNCT07664046
Recruiting
Not Applicable

Diagnostic Value of eVOG

Multiple SclerosisRadiologically Isolated SyndromeWhite Matter Lesions
Centre Hospitalier Universitaire de Nice150 enrolled1 locationNCT05776511
Recruiting
Phase 2

Etrasimod as Prevention of Pouchitis

Pouchitis
Maia Kayal40 enrolled1 locationNCT07486921
Recruiting
Phase 2

CLF065 for Chronic Pouchitis

Pouchitis
Calibr, a division of Scripps Research20 enrolled3 locationsNCT07226050
Recruiting
Phase 2

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

Acute Myeloid LeukemiaMyelodysplastic SyndromeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+11 more
M.D. Anderson Cancer Center508 enrolled1 locationNCT02115295
Recruiting

Lung MRI in Paediatric Lung Disease: MRI in PBB

Protracted bacterial bronchitis
Sheffield Children's NHS Foundation Trust30 enrolled1 locationNCT07545304
Recruiting
Not Applicable

Air-polishing With Erythritol During Orthodontic Tretament

Inflammation GumWhite Spot Lesion
Catherine Giannopoulou60 enrolled1 locationNCT05989750
Recruiting
Phase 4

GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis

Pouchitis
Universitaire Ziekenhuizen KU Leuven20 enrolled1 locationNCT06916390
Recruiting

Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems

Architectural DistortionsBreast Tomosynthesis
M.D. Anderson Cancer Center100 enrolled1 locationNCT06373354
Recruiting
Not Applicable

Evaluation of Cognitive Behavioral Therapy for Insomnia (CBT-I) in Individuals With Mild Traumatic Brain Injury (mTBI)

SleepMild Traumatic Brain InjurySleep Architecture+1 more
University of Missouri-Columbia15 enrolled1 locationNCT07385105
Recruiting
Phase 2

the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Breast CancerNeutropenia (Low White Blood Cell Count)Leucogen+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University94 enrolled1 locationNCT07380646
Recruiting
Not Applicable

Comparative Study of Caries-Preventive Effects: 2% Calcium Hypophosphite Toothpaste vs. Sodium Fluoride Toothpaste (1450ppm F)

Caries,DentalCalcium HypophosphiteFluoridation
Dr. Joachim Enax164 enrolled2 locationsNCT07068204
Recruiting
Not Applicable

Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure

Arterial StiffnessAdultOverweight+13 more
Georgia State University40 enrolled1 locationNCT06735599
Recruiting

Airway Microbiome of Patients With Protracted Bacterial Bronchitis

Protracted bacterial bronchitis
University Hospital, Antwerp160 enrolled1 locationNCT07255430
Recruiting

Evaluation of Musculoskeletal Aging and Related Disorders Via Advanced Clinical Imaging

OsteoporosisOsteoarthitis
Peking University People's Hospital2,000 enrolled1 locationNCT07474571
Recruiting
Not Applicable

White Noise and Crying Duration After Invasive Procedures in Infants

White Noise
Başakşehir Çam & Sakura City Hospital37 enrolled1 locationNCT07453641